Table 2. Octreotide indications.
Courses, n (%)* N = 490 | |
---|---|
Chylothorax | 245 (50) |
Pleural effusion | 158 (32) |
Hypoglycemia | 110 (22) |
Gastrointestinal hemorrhage | 48 (10) |
Bloody stools | 25 (5) |
Pericardial effusion – acute | 13 (3) |
Lymphangiectasia | 3 (1) |
Congenital lymphedema | 1 (0.2) |
Multiple diagnoses per course were allowed; thus, sum of % >100.